TOOMAN CRAIG A

PrivateCIK: 1201050
Location

LONDON, X0

TOOMAN CRAIG A enters SILENCE THERAPEUTICS PLC with 33.49K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderTOOMAN CRAIG ACIK 1201050
IssuerSILENCE THERAPEUTICS PLCCIK 1479615
DirectorOfficer· President and CEO
Since Jan 2025
33.49K
Baseline shares
100% direct
33.49K
Direct ownership
1 position
5.09M
Derivative underlying
7 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned33.49K
Total
33.49K direct33.49K
Derivative Holdings7

Employee Share Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

2.10M

Shares owned

N/A

Exercise price

5.13

Expiration

Exercise window

Employee Share Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

375K

Shares owned

N/A

Exercise price

6.33

Expiration

Exercise window

Employee Share Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

580K

Shares owned

N/A

Exercise price

7.02

Expiration

Exercise window

Employee Share Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

900K

Shares owned

N/A

Exercise price

3.86

Expiration

Exercise window

Employee Share Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

216.96K

Shares owned

N/A

Exercise price

3.33

Expiration

Exercise window

Employee Share Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

650.88K

Shares owned

N/A

Exercise price

5.90

Expiration

Exercise window

Employee Share Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

265K

Shares owned

N/A

Exercise price

7.87

Expiration

Exercise window

Total

Underlying

5.09M

Owned

0.00

TOOMAN CRAIG A — Initial Ownership Disclosure (Form 3) Filed Jan 2, 2025 | Finecho